☆ 4.5 Article

Development and external validation of MRI-based RAS mutation status prediction model for liver metastases of colorectal cancer

JOURNAL OF SURGICAL ONCOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Radiology, Nuclear Medicine & Medical Imaging

Current status and quality of radiomic studies for predicting KRAS mutations in colorectal cancer patients: A systematic review and meta-analysis

Lu-Lu Jia et al.

Summary: The purpose of this study was to evaluate the methodological quality of radiomics-based studies for noninvasive, preoperative prediction of Kirsten rat sarcoma (KRAS) mutations in patients with colorectal cancer. A systematic review and meta-analysis of 29 studies were conducted, revealing that radiomics has a moderate preoperative diagnosis and prediction effect on KRAS mutations. However, it has not been implemented as a clinical decision-making tool. Future research should focus on the methodological quality of the study and further validate the model externally using multicenter datasets.

EUROPEAN JOURNAL OF RADIOLOGY (2023)

添加到收藏夹

Article Surgery

Multisocietal European consensus on the terminology, diagnosis, and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE

Ajith K. Siriwardena et al.

Summary: This article presents a practical framework for managing patients with synchronous colorectal cancer and liver metastases. It discusses the terminology, diagnosis, and management, providing guidance and recommendations for clinicians.

BRITISH JOURNAL OF SURGERY (2023)

添加到收藏夹

Article Oncology

The prognostic impact of RAS on overall survival following liver resection in early versus late-onset colorectal cancer patients

Alexandre A. Jacome et al.

Summary: The study revealed that RAS mutations have a larger negative impact on survival in patients with early-age-onset colorectal cancer, especially in patients under 40 years old. Compared to late-age-onset colorectal cancer patients, RAS mutations in early-age-onset colorectal cancer patients had a more significant effect on survival.

BRITISH JOURNAL OF CANCER (2021)

添加到收藏夹

Article Oncology

Radiomics-Derived Data by Contrast Enhanced Magnetic Resonance in RAS Mutations Detection in Colorectal Liver Metastases

Vincenza Granata et al.

Summary: This study evaluated the association of RAS mutation status and radiomics-derived data using CE-MRI in liver metastases. Texture parameters derived by CE-MRI showed better results compared to morphological metrics in individualized evaluation of CRLM. Multivariate analysis and pattern recognition approaches allowed stratifying the patients according to RAS mutation status.

CANCERS (2021)

添加到收藏夹

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

MRI Findings of Liver Parenchyma Peripheral to Colorectal Liver Metastasis: A Potential Predictor of Long-term Prognosis

Yudai Nakai et al.

RADIOLOGY (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Prognostic significance of doubling time in patients undergoing radical surgery for metachronous peritoneal metastases of colorectal cancer

Hiroaki Miyake et al.

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2019)

添加到收藏夹

Article Medicine, General & Internal

Biomarker concordance between primary colorectal cancer and its metastases

D. S. Bhullar et al.

EBIOMEDICINE (2019)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Relationship between KRAS mutations and dual time point 18F-FDG PET/CT imaging in colorectal liver metastases

Wujian Mao et al.

ABDOMINAL RADIOLOGY (2019)

添加到收藏夹

Article Oncology

Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan A Phase 2 Single-Arm Clinical Trial

Chiara Cremolini et al.

JAMA ONCOLOGY (2019)

添加到收藏夹

Article Surgery

The Tumor Burden Score: A New Metro-ticket Prognostic Tool For Colorectal Liver Metastases Based on Tumor Size and Number of Tumors

Kazunari Sasaki et al.

ANNALS OF SURGERY (2018)

添加到收藏夹

Review Oncology

Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence

Diamantis I. Tsilimigras et al.

SURGICAL ONCOLOGY-OXFORD (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma

Sunyoung Lee et al.

JOURNAL OF HEPATOLOGY (2017)

添加到收藏夹

Article Gastroenterology & Hepatology

Liver-first strategy for synchronous colorectal liver metastases - an intention-to-treat analysis

Christian Sturesson et al.

HPB (2017)

添加到收藏夹

Article Oncology

Effect of KRAS and BRAF Mutations on Survival of Metastatic Colorectal Cancer After Liver Resection: A Systematic Review and Meta-Analysis

Federica Tosi et al.

CLINICAL COLORECTAL CANCER (2017)

添加到收藏夹

Article Oncology

Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015

Carmen J. Allegra et al.

JOURNAL OF CLINICAL ONCOLOGY (2016)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Can Current Preoperative Imaging Be Used to Detect Microvascular Invasion of Hepatocellular Carcinoma?

Matteo Renzulli et al.

RADIOLOGY (2016)

添加到收藏夹

Article Oncology

Analysis of KRAS/NRAS Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal Cancer

Marc Peeters et al.

CLINICAL CANCER RESEARCH (2015)

添加到收藏夹

Article Oncology

Clinicopathologic characteristics and gene expression analyses of non-KRAS 12/13, RAS-mutated metastatic colorectal cancer

V. K. Morris et al.

ANNALS OF ONCOLOGY (2014)

添加到收藏夹

Article Multidisciplinary Sciences

Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer

Sandra Misale et al.

NATURE (2012)

添加到收藏夹

Article Gastroenterology & Hepatology

Heterogeneity of KRAS Status May Explain the Subset of Discordant KRAS Status Between Primary and Metastatic Colorectal Cancer

Toshiaki Watanabe et al.

DISEASES OF THE COLON & RECTUM (2011)

添加到收藏夹

Article Oncology

Prevalence and Heterogeneity of KRAS, BRAF, and PIK3CA Mutations in Primary Colorectal Adenocarcinomas and Their Corresponding Metastases

Stephan E. Baldus et al.

CLINICAL CANCER RESEARCH (2010)

添加到收藏夹

Article Oncology

Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study

Jean-Yves Douillard et al.

JOURNAL OF CLINICAL ONCOLOGY (2010)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.